INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2022

Taurine supplementation reduced MDA and CRP levels in controlled trials, but did not significantly alter TNF-α or IL-6.

A systematic review and dose-response meta-analysis of controlled clinical trials evaluated the impact of taurine supplementation on inflammatory and oxidative stress biomarkers. Taurine significantly decreased levels of MDA (SMD = -1.17 µmol/l; 95% CI: -2.08, -0.26; P = 0.012) and CRP (SMD = -1.95 mg/l; 95% CI: -3.20, -0.71; P = 0.002). No significant effects were observed for TNF-α (SMD = -0.18 pg/ml; 95% CI: -0.56, 0.21; P = 0.368) or IL-6 (SMD = -0.49 pg/ml; 95% CI: -1.13, 0.16; P = 0.141). Time-response analysis showed a more pronounced alleviating effect at 56 days (8 weeks) after supplementation (P < 0.05).

Study type
Systematic review and dose-response meta-analysis of controlled trials
Who was studied
Participants in controlled clinical trials identified up to March 30, 2021
What was measured
Levels of malondialdehyde (MDA), C-reactive protein (CRP), TNF-α, and IL-6

THE PAPER

Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials.

Faghfouri AH, Seyyed Shoura SM, Fathollahi P, Shadbad MA, Papi S, Ostadrahimi A, Faghfuri E. Eur J Clin Nutr, 2022.

PubMed 34584225 ↗DOI 10.1038/s41430-021-01010-4 ↗

Nutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.